Kestra Medical Technologies
KMTS
107 hedge funds and large institutions have $1.49B invested in Kestra Medical Technologies in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 51 increasing their positions, 11 reducing their positions, and 6 closing their positions.
450% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 6
364% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 11
34% more funds holding
Funds holding: 80 → 107 (+27)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
30% more capital invested
Capital invested by funds: $1.15B → $1.49B (+$339M)
2.17% more ownership
Funds ownership: 94.07% → 96.23% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$65.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$15.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.4M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCI
Bain Capital Investors
Boston,
Massachusetts
|
-$47.6M |
| 2 |
Holocene Advisors
New York
|
-$18.6M |
| 3 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$7.01M |
| 4 |
LP
Longaeva Partners
Chicago,
Illinois
|
-$3.08M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$1.71M |
KMTS Hedge Fund Activity: Q4 2025 in Review
107 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q4 2025, worth a combined $1.49B — up 30% from $1.15B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new KMTS positions and 6 closed out — a net gain of 27 holders — while 51 added to existing stakes and 11 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $65.2M. The largest seller was Bain Capital Investors, cutting an estimated $47.6M.
- 107 institutional investors held Kestra Medical Technologies (KMTS) as of Q4 2025, up from 80 in Q3 2025.
- Funds reported $1.49B of Kestra Medical Technologies stock for Q4 2025, up 30% quarter-over-quarter.
- 33 funds opened new Kestra Medical Technologies positions in Q4 2025 and 6 closed out, a net change of +27 holders.
- The largest Kestra Medical Technologies buyer in Q4 2025 was T. Rowe Price Associates, an estimated $65.2M added.
- The largest Kestra Medical Technologies seller in Q4 2025 was Bain Capital Investors, an estimated $47.6M sold.
Based on aggregated 13F filings for Q4 2025.